ValiRx (LSE:VAL) has reinforced the intellectual property position of its majority-owned subsidiary Cytolytix after securing ...

If you want to know who really controls ValiRx plc (LON:VAL), then you'll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect to see ...

ValiRx, the AIM-listed life sciences company focused on early-stage cancer therapeutics and women's health, has raised up to ...

We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks ValiRx plc ( (GB:VAL)) has issued an ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs ...

Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of efficacy in advanced prostate cancer in its first clinical trial. The company reported results ...

London, UK., 14 January 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, provides the following update on its subsidiary joint venture, ValiSeek, and its cancer therapeutic, ...

LONDON - ValiRx Plc (AIM: VAL), a life science company specializing in early-stage cancer therapeutics and women's health, has announced the extension of its Letter of Intent (LOI) with TheoremRx Inc.

"Through the application of novel personalised therapeutic and early diagnostic therapies" London, UK., 09 January 2019: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, is pleased to ...

Deal includes an HPV test and two platforms for cancer tests. Biofield gained exclusive, worldwide distribution rights outside of Belgium for ValiRx’ HPV diagnostic for cervical cancer as well as its ...